These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2391448)

  • 1. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
    Streck RJ; Helinski EH; Ovak GM; Pauly JL
    J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-cytolytic human macrophages cultured as nonadherent cells: potential for the adoptive immunotherapy of cancer.
    Helinski EH; Hurley EL; Streck RJ; Bielat KL; Pauly JL
    Cancer Detect Prev; 1990; 14(4):471-81. PubMed ID: 2224910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
    Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
    Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
    J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic analysis of human lymphokine-activated killer (LAK) cells.
    Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H
    Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV; Ludwig WD; Thiel E
    Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
    Basu S; Sodhi A
    Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of IL-2 and IL-2R SNPs on proliferation and tumor- killing activity of lymphokine-activated killer cells from healthy chinese blood donors.
    Li Y; Meng FD; Tian X; Sui CG; Liu YP; Jiang YH
    Asian Pac J Cancer Prev; 2014; 15(18):7965-70. PubMed ID: 25292096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of human alveolar macrophages by lymphokine-activated killer cells.
    Maruyama M; Kawasaki A; Suzuki H; Yamashita N; Yano S
    Chest; 1990 Jun; 97(6):1372-6. PubMed ID: 2347221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of IL-2 induces lymphokine-activated killer (LAK) cells capable of killing macrophages in various tissues.
    Kamitani T; Suzuki H; Yano S
    Immunology; 1989 Dec; 68(4):520-5. PubMed ID: 2606510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
    Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitro.
    Hook GR; Greenwood MA; Barba D; Ikejiri B; Chen SN; Oldfield EH; Weber RJ; Muul LM
    J Natl Cancer Inst; 1988 Apr; 80(3):171-7. PubMed ID: 3258038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
    Melder RJ; Walker ER; Herberman RB; Whiteside TL
    J Leukoc Biol; 1990 Aug; 48(2):163-73. PubMed ID: 1973444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.
    Pavletic Z; Benyunes MC; Thompson JA; Lindgren CG; Massumoto C; Alderson MR; Buckner CD; Fefer A
    Exp Hematol; 1993 Sep; 21(10):1371-8. PubMed ID: 8359237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.
    Lamers HJ; Gratama JW; van Putten WL; Stoter G; Bolhuis RL
    Cancer Res; 1991 May; 51(9):2324-8. PubMed ID: 2015597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of murine macrophages by lymphokine-activated killer-like cells induced by BCG in vitro.
    Chen MF; Suzuki H; Yano S
    Microbiol Immunol; 1991; 35(7):557-67. PubMed ID: 1784257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
    Böhm M; Möller P; Kalbfleisch U; Worm M; Czarnetzki BM; Schadendorf D
    Br J Cancer; 1994 Jul; 70(1):54-9. PubMed ID: 8018541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.